Clinical Report: Multimodal Machine Learning Model for Osteoporosis in T2DM

Overview

This study developed a multimodal machine learning model to detect osteoporosis in patients with type 2 diabetes mellitus (T2DM), achieving high accuracy in identifying osteoporosis risk. The model integrates various clinical data.

Background

Osteoporosis is a significant complication in T2DM patients, increasing fracture risk and mortality. Current screening methods are often inadequate. This study utilizes machine learning to enhance osteoporosis detection in this high-risk population.

Data Highlights

Key Findings

• Seven predictors identified: age, hemoglobin, neutrophil count, uric acid, lymphocyte-to-HDL ratio, skeletal muscle index at L3, and metabolic score for visceral fat.
• The eXtreme Gradient Boosting (XGBoost) model outperformed other algorithms in predicting osteoporosis risk.
• SHAP analysis indicated age, hemoglobin, and uric acid as the most significant contributors to the model.
• Calibration and decision curve analyses confirmed the model's clinical utility.
• The prevalence of osteoporosis among T2DM patients in China is estimated at 35%, projected to rise to 40.8% by 2030.

Clinical Implications

Further prospective validation is necessary to establish the clinical utility of the developed model.

Conclusion

This study presents a robust machine learning model for osteoporosis risk prediction in T2DM.

Related Resources & Content

1. Frontiers in Endocrinology, 2026 -- An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study
2. Frontiers in Medicine, 2026 -- Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data
3. Frontiers in Endocrinology, 2026 -- Development and external validation of an interpretable machine learning model for diagnosing coronary heart disease in patients with type 2 diabetes and MASLD
4. Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
5. Updated December 2024 -- NOGG Guideline 2024
6. Frontiers in Endocrinology — Interpretable machine learning for predicting major amputation risk in hospitalized diabetic foot ulcer patients: a single-center study with temporal external validation
7. Clinical Use of Trabecular Bone Score: The 2023 ISCD Official Positions
8. Increased bone fragility in diabetes mellitus
9. Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
10. Updated December 2024
11. Biases in the performance of FRAX without BMD in predicting fracture risk in a multiethnic population with diabetes: the Diabetes and Aging Study
12. Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis - PubMed
13. Association between type 2 diabetes and site‐specific fracture risk: A systematic review and meta‐analysis of cohort studies including over 13 million participants - PMC
14. The Impact of Different Antidiabetic Drugs on Fracture Risk in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials With a Focus on SGLT2 Inhibitors - PubMed
15. Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis - PubMed
16. Clinical implications of fracture severity risk with pioglitazone: a systematic review and meta-analysis of clinical randomized trials - PubMed
17. Bone microstructure and TBS in diabetes: what have we learned? A narrative review - PubMed